Non-inflammatory breast cancerp-value |
Patients presentations |
N 0 |
miR-335 |
miR-24 |
miR-320 |
miR-548d-5p |
miR-342-5p |
miR-15a |
miR-342-3p |
miR-29a |
miR-451 |
miR-30b |
miR-337-5p |
miR-486-3p |
Age |
≥40 years |
7 |
0.598 |
0.257 |
0.064 |
0.548 |
0.072 |
0.442 |
0.187 |
0.249 |
0.193 |
0.094 |
0.297 |
0.774 |
<40 years |
13 |
|
|
|
|
|
|
|
|
|
|
|
|
Menopausal State |
Premenopausal |
10 |
0.007 |
0.01 |
0.297 |
0.087 |
0.71 |
0.971 |
0.063 |
0.087 |
0.81 |
0.73 |
0.118 |
0.301 |
Postmenopausal |
10 |
|
|
|
|
|
|
|
|
|
|
|
|
Parity |
yes |
12 |
0.574 |
0.591 |
0.112 |
0.397 |
0.035 |
0.91 |
0.054 |
0.314 |
0.831 |
0.79 |
0.071 |
0.068 |
No |
8 |
|
|
|
|
|
|
|
|
|
|
|
|
ER status |
Negative |
9 |
0.75 |
0.074 |
0.221 |
0.319 |
0.345 |
0.208 |
0.614 |
0.068 |
0.324 |
0.217 |
0.007 |
0.864 |
Positive |
11 |
|
|
|
|
|
|
|
|
|
|
|
|
PR status |
Negative |
8 |
0.904 |
0.253 |
0.812 |
0.627 |
0.121 |
0.876 |
0.531 |
0.064 |
0.053 |
0.072 |
0.065 |
0.907 |
Positive |
12 |
|
|
|
|
|
|
|
|
|
|
|
|
Her2 overexpression |
Negative |
13 |
0.523 |
0.739 |
0,513 |
0.201 |
0.257 |
0.384 |
0.201 |
0.087 |
0.987 |
0.201 |
0.214 |
0.259 |
Positive |
7 |
|
|
|
|
|
|
|
|
|
|
|
|
Lymph Node Involvement |
No |
7 |
0.084 |
0.315 |
0.07 |
0.411 |
0.487 |
0.214 |
0.187 |
0.458 |
0.573 |
0.72 |
0.571 |
0.201 |
Yes |
13 |
|
|
|
|
|
|
|
|
|
|
|
|
Tumor Size |
T1-T2 |
6 |
0.091 |
0.082 |
0.741 |
0.841 |
0.385 |
0.871 |
0.397 |
0.097 |
0.067 |
0.854 |
0.197 |
0.154 |
T3-T4 |
14 |
|
|
|
|
|
|
|
|
|
|
|
|
Tumor Grade |
II |
7 |
0.372 |
0.218 |
0.397 |
0.871 |
0.222 |
0.287 |
0.179 |
0.214 |
0.91 |
0.418 |
0.227 |
0.128 |
III |
13 |
|
|
|
|
|
|
|
|
|
|
|
|
Metastasis |
No |
16 |
0.09 |
0.55 |
0.433 |
0.287 |
0.454 |
0.321 |
0.074 |
0.27 |
0.852 |
0.082 |
0.812 |
0.875 |
Yes |
4 |
|
|
|
|
|
|
|
|
|
|
|
|
Bold letters represent p < 0.05, significant. |
|